Ravelcare FY26 net profit rises 1.3% to ₹515.40 crore

1 min read     Updated on 31 May 2026, 01:22 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Ravelcare Limited reported a 1.3% rise in net profit to ₹515.40 crore for FY26, with revenue from operations increasing to ₹2695.43 crore. The board approved the audited financial results and re-appointed internal auditors M/s. Mahesh Dhabalia & Co. for FY 2026-27.

powered bylight_fuzz_icon
41270043

*this image is generated using AI for illustrative purposes only.

Ravelcare Limited reported a net profit of ₹515.40 crore for the financial year ended March 31, 2026, representing a 1.3% increase compared to ₹508.56 crore in the previous year. Revenue from operations for the year stood at ₹2695.43 crore, up from ₹2497.89 crore in FY25. The board approved the audited financial results for the half year and full year ended March 31, 2026, at a meeting held on May 30, 2026.

The statutory auditors issued an audit report with an unmodified opinion on the financial results for the year ended March 31, 2026. For the half year ended March 31, 2026, the company reported a net profit of ₹195.13 crore, while revenue from operations was ₹1255.67 crore. Total income for the full year rose to ₹2703.71 crore from ₹2529.80 crore in the prior year.

The board also approved the re-appointment of M/s. Mahesh Dhabalia & Co., Chartered Accountants, as internal auditors for the financial year 2026-27. The re-appointment is effective from May 30, 2026. The meeting commenced at 8:00 p.m. and concluded at 8:30 p.m.

Financial Results Summary

Particulars Year Ended 31/03/2026 (₹ In Lakh) Year Ended 31/03/2025 (₹ In Lakh)
Revenue from Operations 2695.43 2497.89
Total Income 2703.71 2529.80
Total Expenses 1996.46 1826.44
Profit Before Tax 707.25 703.36
Net Profit 515.40 508.56
Basic EPS (₹) 9.20 10.16

The trading window for dealing in the shares of Ravelcare Limited, which was closed since April 01, 2026, will reopen 48 hours after the conclusion of the board meeting.

Historical Stock Returns for Ravelcare

1 Day5 Days1 Month6 Months1 Year5 Years
-1.23%-26.84%-33.32%-32.97%-32.97%-32.97%

What strategic initiatives will Ravelcare undertake to improve profit margins given the modest 1.3% profit growth compared to revenue expansion?

How does the company plan to address the decline in Basic EPS from ₹10.16 to ₹9.20 despite the increase in net profit?

What are the management's revenue and profitability targets for the upcoming fiscal year 2026-27?

Ravelcare Limited Board Meeting Outcome: Appoints Company Secretary & Compliance Officer

1 min read     Updated on 17 Mar 2026, 08:06 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Ravelcare Limited has officially announced the appointment of Mr. Alpesh Rajesh Bhatt as Company Secretary and Compliance Officer through a formal board meeting outcome on March 17, 2026. The appointment was approved by the Board of Directors based on the Nomination and Remuneration Committee's recommendation, with full compliance to SEBI regulations and proper disclosure to BSE Limited.

powered bylight_fuzz_icon
35300420

*this image is generated using AI for illustrative purposes only.

Ravelcare Limited has officially announced the appointment of Mr. Alpesh Rajesh Bhatt as the company's new Company Secretary and Compliance Officer through a formal board meeting outcome. The appointment, which took effect on March 17, 2026, was approved by the Board of Directors following a recommendation from the Nomination and Remuneration Committee.

Board Meeting Outcome

The board meeting held on Tuesday, March 17, 2026, formally approved Mr. Bhatt's appointment as a Key Managerial Personnel (KMP) of the company. The company has communicated this decision to BSE Limited through an official filing under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter: Details
Position: Company Secretary and Compliance Officer (KMP)
Effective Date: March 17, 2026
Term of Appointment: Not Applicable
Approval Authority: Board of Directors
Recommendation: Nomination and Remuneration Committee
Scrip Code: 544629

Professional Background and Qualifications

Mr. Alpesh Rajesh Bhatt brings significant expertise to his new role at Ravelcare Limited. According to the official disclosure, his professional credentials include:

Qualification: Details
Professional Membership: Associate member of the Institute of Company Secretaries of India
Experience: Veteran professional in secretarial compliances and legal matters
Educational Background: Post-graduation degree from prominent institution
Legal Qualification: LLB from prominent institution
Shareholding: Not Applicable

Regulatory Compliance and Documentation

The appointment has been made in full compliance with SEBI regulations. The company has provided comprehensive disclosures as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023.

The official communication was signed by Maheshkumar Ramchandra Varma, Whole-time Director (DIN: 09756885), and submitted to BSE Limited for necessary records. The company maintains its registered office at Off-126, Neo Corporate Plaza, Malad West, Mumbai, Maharashtra 400064.

Strategic Significance

The appointment of Mr. Bhatt as Company Secretary and Compliance Officer represents an important step in strengthening Ravelcare Limited's governance framework. His role as a Key Managerial Personnel will be crucial in ensuring the company maintains high standards of regulatory compliance and corporate governance practices, particularly given his extensive background in secretarial compliances and legal matters.

Historical Stock Returns for Ravelcare

1 Day5 Days1 Month6 Months1 Year5 Years
-1.23%-26.84%-33.32%-32.97%-32.97%-32.97%

What strategic initiatives might Ravelcare Limited be planning that necessitated strengthening their compliance framework with this key appointment?

How could Mr. Bhatt's legal expertise influence Ravelcare's approach to upcoming regulatory changes in the healthcare sector?

Will this governance enhancement position Ravelcare for potential expansion into new markets or business segments?

1 Year Returns:-32.97%